Title : Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.

Pub. Date : 2004 Sep

PMID : 15529521






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. Rosiglitazone insulin Homo sapiens
2 Metformin (a biguanide) and rosiglitazone (a thiazolidinedione) counter insulin resistance, acting by different cellular mechanisms. Rosiglitazone insulin Homo sapiens